ESTRADIOL VALERATE

ESTRADIOL VALERATE was reported 778 times

ESTRADIOL VALERATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE LENTIGINES SYNDROME 14 0.3684
1 INTRANASAL NUMBNESS 1 0.1250
2 ENDOMETRIOSIS MALE 1 0.1250
3 ASPIRATION BREAST 1 0.1111
4 GENDER REASSIGNMENT THERAPY 1 0.0909
5 BLOOD CORTICOSTERONE DECREASED 1 0.0833
6 CONGENITAL ASTIGMATISM 2 0.0800
7 BRONCHOGENIC CYST 2 0.0741
8 LARYNGOCELE 1 0.0667
9 ACTINOMYCOTIC SKIN INFECTION 2 0.0588
10 MYOSITIS-LIKE SYNDROME 1 0.0556
11 HYPOTONIC URINARY BLADDER 7 0.0515
12 DECREASED EMBRYO VIABILITY 1 0.0417
13 CAROTID ARTERIAL EMBOLUS 2 0.0377
14 OESTRADIOL ABNORMAL 2 0.0303
15 DIABETIC RETINAL OEDEMA 15 0.0295
16 VESTIBULAR MIGRAINE 7 0.0290
17 CEREBRAL ARTERITIS 1 0.0286
18 DEPRESSIVE DELUSION 1 0.0286
19 CONGENITAL KNEE DEFORMITY 2 0.0278
20 CLINOMANIA 1 0.0263
21 PHYLLODES TUMOUR 2 0.0247
22 CATARACT SUBCAPSULAR 15 0.0246
23 EPISCLERITIS 15 0.0217
24 INTESTINAL ADENOCARCINOMA 4 0.0214
25 EMBRYONAL RHABDOMYOSARCOMA 1 0.0192
26 BEREAVEMENT REACTION 1 0.0169
27 NO ADVERSE REACTION 2 0.0137
28 TINEA INFECTION 15 0.0136
29 MITRAL VALVE ATRESIA 1 0.0114
30 PARASOMNIA 8 0.0111
31 TINEA PEDIS 15 0.0094
32 ABORTION EARLY 1 0.0093
33 CERVIX DYSTOCIA 1 0.0088
34 HABITUAL ABORTION 1 0.0088
35 OVARIAN HYPERSTIMULATION SYNDROME 20 0.0086
36 OVERLAP SYNDROME 6 0.0086
37 DUPUYTREN'S CONTRACTURE 1 0.0084
38 BREAST INFECTION 1 0.0083
39 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
40 HYSTEROSCOPY 1 0.0080
41 CYSTOID MACULAR OEDEMA 15 0.0080
42 PROLACTINOMA 1 0.0077
43 ENZYME LEVEL DECREASED 1 0.0076
44 ILIAC ARTERY STENOSIS 1 0.0076
45 PH BODY FLUID ABNORMAL 1 0.0072
46 PRODUCT CLOSURE ISSUE 4 0.0072
47 HAEMORRHAGIC ASCITES 2 0.0070
48 PELIOSIS HEPATIS 1 0.0069
49 DILATATION INTRAHEPATIC DUCT ACQUIRED 2 0.0068
50 BLOOD OESTROGEN INCREASED 4 0.0068
51 CONGENITAL TRICUSPID VALVE ATRESIA 1 0.0067
52 OESTRADIOL INCREASED 2 0.0066
53 OESTRADIOL DECREASED 2 0.0062
54 FIBROMUSCULAR DYSPLASIA 1 0.0061
55 GASTROENTERITIS RADIATION 2 0.0061
56 ANAEMIA VITAMIN B12 DEFICIENCY 3 0.0061
57 LIP SQUAMOUS CELL CARCINOMA 1 0.0060
58 BLOOD OESTROGEN ABNORMAL 1 0.0058
59 HAEMOCONCENTRATION 1 0.0058
60 SYSTEMIC SCLERODERMA 4 0.0055
61 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
62 SCLERODERMA RENAL CRISIS 2 0.0053
63 MEDIASTINAL MASS 2 0.0052
64 EAR CONGESTION 14 0.0052
65 BRACHYDACTYLY 1 0.0051
66 ALCOHOLIC 1 0.0050
67 PITUITARY ENLARGEMENT 1 0.0049
68 WAIST CIRCUMFERENCE INCREASED 5 0.0048
69 DENTAL FISTULA 2 0.0048
70 BACTERIAL DIARRHOEA 1 0.0047
71 PRODUCT ADVERTISING ISSUE 1 0.0047
72 BREAST ATROPHY 1 0.0045
73 HEPATIC RUPTURE 1 0.0045
74 DIABETIC RETINOPATHY 15 0.0044
75 BONE INFARCTION 2 0.0044
76 BREAST LUMP REMOVAL 1 0.0044
77 BLOOD OESTROGEN DECREASED 3 0.0043
78 PELVIC FLUID COLLECTION 3 0.0043
79 INJECTION SITE GRANULOMA 1 0.0042
80 AGNOSIA 1 0.0042
81 BLADDER MASS 2 0.0040
82 PLAGIOCEPHALY 2 0.0040
83 EPILEPTIC AURA 1 0.0039
84 EYE HAEMATOMA 1 0.0038
85 BLOOD CORTISOL INCREASED 1 0.0038
86 INFECTED BITES 1 0.0037
87 PARATHYROID TUMOUR 1 0.0036
88 ENDOMETRIAL CANCER 8 0.0036
89 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 2 0.0036
90 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
91 AORTIC CALCIFICATION 2 0.0034
92 MIGRAINE WITHOUT AURA 1 0.0033
93 HEAD DEFORMITY 1 0.0033
94 PERNICIOUS ANAEMIA 2 0.0032
95 ANOREXIA NERVOSA 1 0.0031
96 OXYGEN SATURATION INCREASED 1 0.0029
97 JOINT ABSCESS 1 0.0029
98 FOETAL HYPOKINESIA 2 0.0029
99 PUBIS FRACTURE 2 0.0028
100 MACULAR OEDEMA 15 0.0027
101 BODY DYSMORPHIC DISORDER 1 0.0027
102 PATERNAL DRUGS AFFECTING FOETUS 1 0.0027
103 KERATOCONUS 1 0.0027
104 COMPLICATION OF PREGNANCY 2 0.0026
105 OBSTRUCTIVE PANCREATITIS 2 0.0026
106 OVARIAN ENLARGEMENT 1 0.0026
107 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 1 0.0026
108 PULMONARY ARTERY STENOSIS 1 0.0026
109 PREGNANCY TEST POSITIVE 1 0.0025
110 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
111 DEATH OF RELATIVE 1 0.0025
112 GIANT CELL ARTERITIS 2 0.0024
113 BONE NEOPLASM MALIGNANT 1 0.0024
114 OROPHARYNGEAL SPASM 1 0.0024
115 APPARENT LIFE THREATENING EVENT 1 0.0024
116 FIBROADENOMA OF BREAST 1 0.0022
117 ANAEMIA OF CHRONIC DISEASE 2 0.0022
118 ABSCESS ORAL 3 0.0022
119 BODY MASS INDEX DECREASED 1 0.0022
120 DYSPHASIA 1 0.0021
121 MAGNESIUM DEFICIENCY 1 0.0021
122 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
123 THERMAL BURN 15 0.0021
124 HEPATIC HAEMATOMA 1 0.0021
125 ACTINOMYCOSIS 2 0.0021
126 PERIPHERAL ARTERY STENOSIS 1 0.0021
127 VAGINAL DISORDER 2 0.0021
128 HOARSENESS 1 0.0021
129 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
130 CERVICAL INCOMPETENCE 1 0.0020
131 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
132 DEVICE USE CONFUSION 1 0.0019
133 VASCULAR CALCIFICATION 2 0.0019
134 GALLBLADDER ENLARGEMENT 2 0.0019
135 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
136 MENINGITIS TUBERCULOUS 1 0.0018
137 BURNING MOUTH SYNDROME 1 0.0018
138 ACUTE SINUSITIS 3 0.0017
139 PLEOCYTOSIS 1 0.0017
140 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
141 AMBLYOPIA 1 0.0017
142 APHTHOUS ULCER 13 0.0017
143 INDUCED LABOUR 1 0.0017
144 OTITIS EXTERNA 2 0.0016
145 FISTULA DISCHARGE 2 0.0016
146 ABORTION MISSED 2 0.0016
147 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
148 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
149 DIZZINESS POSTURAL 15 0.0015
150 INTESTINAL DILATATION 2 0.0015
151 MAMMOGRAM ABNORMAL 1 0.0015
152 HEPATITIS B DNA INCREASED 1 0.0015
153 MARROW HYPERPLASIA 1 0.0015
154 CONGENITAL HAND MALFORMATION 1 0.0015
155 GRAVITATIONAL OEDEMA 1 0.0014
156 PERIODONTAL DISEASE 2 0.0014
157 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
158 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
159 PCO2 INCREASED 1 0.0014
160 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
161 HAEMORRHAGE IN PREGNANCY 2 0.0014
162 CARDIAC SEPTAL DEFECT 1 0.0014
163 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
164 FINGER AMPUTATION 1 0.0014
165 BILIARY DILATATION 2 0.0014
166 LEGAL PROBLEM 1 0.0014
167 FIBROCYSTIC BREAST DISEASE 1 0.0014
168 LIMB CRUSHING INJURY 1 0.0013
169 GINGIVAL ABSCESS 1 0.0013
170 LIGAMENT SPRAIN 13 0.0013
171 ECTOPIC PREGNANCY 4 0.0013
172 MENOPAUSAL SYMPTOMS 3 0.0013
173 PULMONARY FUNCTION TEST ABNORMAL 2 0.0013
174 GRIMACING 1 0.0013
175 PLACENTA PRAEVIA 1 0.0013
176 ENDOMETRIAL HYPERPLASIA 1 0.0012
177 DRUG LEVEL DECREASED 12 0.0012
178 BURSITIS 14 0.0012
179 FOOD INTERACTION 2 0.0011
180 POLYMYOSITIS 2 0.0011
181 EYE HAEMORRHAGE 15 0.0011
182 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
183 THERAPEUTIC RESPONSE CHANGED 7 0.0011
184 LIGAMENT DISORDER 1 0.0011
185 BIOPSY 1 0.0011
186 PROGESTERONE RECEPTOR ASSAY POSITIVE 1 0.0011
187 PSYCHOGENIC SEIZURE 1 0.0011
188 PLACENTAL DISORDER 1 0.0011
189 COR PULMONALE 1 0.0010
190 BONE SWELLING 1 0.0010
191 HORMONE LEVEL ABNORMAL 5 0.0010
192 DEVICE RELATED THROMBOSIS 1 0.0010
193 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
194 BREAST DISORDER 2 0.0010
195 THYROID DISORDER 15 0.0010
196 CAROTID ARTERIOSCLEROSIS 1 0.0010
197 BREAST NEOPLASM 1 0.0010
198 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
199 CONSCIOUSNESS FLUCTUATING 1 0.0010
200 COGWHEEL RIGIDITY 1 0.0010
201 HEPATIC NEOPLASM MALIGNANT 2 0.0009
202 TORTICOLLIS 2 0.0009
203 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
204 NEUROMYOPATHY 1 0.0009
205 SENSORY DISTURBANCE 15 0.0009
206 TEARFULNESS 4 0.0009
207 VULVOVAGINAL DRYNESS 3 0.0009
208 JAW FRACTURE 2 0.0009
209 HYPERPROLACTINAEMIA 6 0.0009
210 PERIRECTAL ABSCESS 1 0.0009
211 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
212 CHRONIC GASTRITIS 2 0.0009
213 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
214 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
215 ORAL PRURITUS 2 0.0009
216 PATELLA FRACTURE 2 0.0009
217 VAGINAL INFECTION 4 0.0008
218 LYMPHOCYTE COUNT DECREASED 15 0.0008
219 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
220 MUSCULOSKELETAL CHEST PAIN 13 0.0008
221 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
222 RADIUS FRACTURE 2 0.0008
223 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
224 REFLUX GASTRITIS 1 0.0008
225 RENAL TRANSPLANT 3 0.0008
226 BIPOLAR DISORDER 9 0.0008
227 EJECTION FRACTION ABNORMAL 1 0.0008
228 SCIATICA 13 0.0008
229 NEPHRITIS INTERSTITIAL 1 0.0008
230 NECROTISING COLITIS 1 0.0008
231 BLOOD BILIRUBIN ABNORMAL 1 0.0008
232 OVARIAN CYST RUPTURED 1 0.0008
233 PRODUCT COLOUR ISSUE 4 0.0008
234 AORTIC ARTERIOSCLEROSIS 2 0.0008
235 GESTATIONAL HYPERTENSION 1 0.0008
236 RADICULOPATHY 2 0.0008
237 FEELING GUILTY 1 0.0008
238 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
239 HIRSUTISM 1 0.0008
240 BACTERIAL INFECTION 14 0.0007
241 BODY MASS INDEX INCREASED 1 0.0007
242 OFF LABEL USE OF DEVICE 1 0.0007
243 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
244 MENISCUS LESION 1 0.0007
245 ORAL HERPES 14 0.0007
246 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
247 INTESTINAL FISTULA 1 0.0007
248 CATAPLEXY 1 0.0007
249 BREAST CANCER STAGE IV 2 0.0007
250 NOROVIRUS INFECTION 1 0.0007
251 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
252 ABORTION 2 0.0007
253 STRABISMUS 2 0.0007
254 GENERALISED ANXIETY DISORDER 1 0.0007
255 ANKLE OPERATION 1 0.0007
256 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
257 PITUITARY TUMOUR 1 0.0007
258 EPICONDYLITIS 1 0.0007
259 BLOOD PRESSURE IMMEASURABLE 1 0.0007
260 ORAL MUCOSAL ERUPTION 1 0.0007
261 PREMATURE SEPARATION OF PLACENTA 1 0.0006
262 COAGULATION TIME PROLONGED 1 0.0006
263 TALIPES 2 0.0006
264 OPHTHALMOPLEGIA 1 0.0006
265 ABDOMINAL ADHESIONS 2 0.0006
266 KERATOPATHY 1 0.0006
267 NEONATAL DISORDER 1 0.0006
268 ENDOMETRIOSIS 3 0.0006
269 COSTOCHONDRITIS 1 0.0006
270 PITUITARY TUMOUR BENIGN 1 0.0006
271 BODY TEMPERATURE DECREASED 6 0.0006
272 LISTLESS 2 0.0006
273 SUSPECTED COVID-19 2 0.0006
274 PATHOLOGICAL GAMBLING 1 0.0006
275 OLIGOHYDRAMNIOS 2 0.0006
276 ECONOMIC PROBLEM 9 0.0006
277 ULCER HAEMORRHAGE 4 0.0006
278 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1 0.0006
279 NEUROPATHY 1 0.0006
280 LAZINESS 1 0.0006
281 BLOOD PH DECREASED 1 0.0006
282 PERIPHERAL VASCULAR DISORDER 3 0.0006
283 CERVICAL SPINAL STENOSIS 1 0.0006
284 AMYLOIDOSIS 1 0.0006
285 EAR PRURITUS 2 0.0006
286 MUSCLE CRAMP 1 0.0006
287 STRESS FRACTURE 3 0.0006
288 NASAL OEDEMA 1 0.0006
289 ALCOHOL USE 2 0.0005
290 BLOOD PRESSURE FLUCTUATION 13 0.0005
291 INJECTION SITE CELLULITIS 1 0.0005
292 LOSS OF CONTROL OF LEGS 2 0.0005
293 MYELOPATHY 1 0.0005
294 BREAST CANCER FEMALE 14 0.0005
295 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
296 ORAL INFECTION 2 0.0005
297 NASAL SEPTUM DEVIATION 1 0.0005
298 PYELONEPHRITIS ACUTE 1 0.0005
299 PREMATURE DELIVERY 8 0.0005
300 RESTLESS LEGS SYNDROME 9 0.0005
301 EYELID PAIN 1 0.0005
302 NIPPLE PAIN 1 0.0005
303 CHANGE OF BOWEL HABIT 1 0.0005
304 MICROCYTIC ANAEMIA 1 0.0005
305 SUICIDAL BEHAVIOUR 2 0.0005
306 INSULIN RESISTANCE 1 0.0005
307 FUNGAL INFECTION 16 0.0005
308 WEIGHT FLUCTUATION 5 0.0005
309 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
310 MIGRAINE 45 0.0005
311 BREAST PAIN 5 0.0005
312 SKIN CANCER 10 0.0005
313 SOMNAMBULISM 3 0.0005
314 HYPERKALAEMIA 16 0.0005
315 SPINAL OSTEOARTHRITIS 4 0.0005
316 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
317 MYOSITIS 4 0.0004
318 READING DISORDER 1 0.0004
319 BREAKTHROUGH PAIN 1 0.0004
320 HEART RATE DECREASED 15 0.0004
321 EOSINOPHIL COUNT DECREASED 1 0.0004
322 BRONCHITIS CHRONIC 1 0.0004
323 PANCREATIC DISORDER 2 0.0004
324 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
325 HEPATOCELLULAR CARCINOMA 3 0.0004
326 CANCER PAIN 1 0.0004
327 DISSEMINATED TUBERCULOSIS 1 0.0004
328 GAIT INABILITY 13 0.0004
329 CEREBRAL ISCHAEMIA 2 0.0004
330 LIPOMA 1 0.0004
331 FOETAL DEATH 2 0.0004
332 FAILURE TO THRIVE 2 0.0004
333 BURNING SENSATION 27 0.0004
334 HEPATITIS TOXIC 1 0.0004
335 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
336 PREGNANCY ON ORAL CONTRACEPTIVE 1 0.0004
337 NASAL DISORDER 1 0.0004
338 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
339 ABORTION SPONTANEOUS 15 0.0004
340 QUALITY OF LIFE DECREASED 5 0.0004
341 BREAST SWELLING 1 0.0004
342 VIROLOGIC FAILURE 2 0.0004
343 MIGRAINE WITH AURA 1 0.0004
344 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
345 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
346 EOSINOPHILIC OESOPHAGITIS 1 0.0004
347 LIVE BIRTH 3 0.0004
348 PRODUCT LEAKAGE 2 0.0004
349 PREMATURE LABOUR 2 0.0004
350 CHOLECYSTITIS ACUTE 2 0.0004
351 JOINT LOCK 1 0.0004
352 MICTURITION URGENCY 4 0.0003
353 PSEUDOMONAS INFECTION 3 0.0003
354 MUSCULOSKELETAL PAIN 18 0.0003
355 HYPERTRIGLYCERIDAEMIA 2 0.0003
356 MIXED LIVER INJURY 1 0.0003
357 CEREBROVASCULAR DISORDER 1 0.0003
358 FOETAL GROWTH RESTRICTION 2 0.0003
359 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
360 CARDIAC FAILURE CONGESTIVE 26 0.0003
361 PRE-EXISTING CONDITION IMPROVED 2 0.0003
362 PORTAL VEIN THROMBOSIS 1 0.0003
363 ANAPHYLACTIC REACTION 17 0.0003
364 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
365 FACET JOINT SYNDROME 1 0.0003
366 COELIAC DISEASE 3 0.0003
367 BREAST ENLARGEMENT 1 0.0003
368 ANHEDONIA 8 0.0003
369 INJECTION SITE INFECTION 1 0.0003
370 PRODUCT FORMULATION ISSUE 2 0.0003
371 RECTAL HAEMORRHAGE 13 0.0003
372 PEPTIC ULCER 1 0.0003
373 EYE PAIN 17 0.0003
374 ANXIETY DISORDER 1 0.0003
375 CERVICAL VERTEBRAL FRACTURE 1 0.0003
376 HYPOPNOEA 1 0.0003
377 CAROTID ARTERY STENOSIS 1 0.0003
378 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
379 HANGOVER 1 0.0003
380 DEPRESSIVE SYMPTOM 1 0.0003
381 HEART DISEASE CONGENITAL 1 0.0003
382 LUNG TRANSPLANT 1 0.0003
383 MACULOPATHY 1 0.0003
384 PRODUCT CONTAMINATION 1 0.0003
385 BREAST CANCER METASTATIC 3 0.0003
386 HERPES ZOSTER 16 0.0003
387 DECREASED ACTIVITY 3 0.0003
388 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
389 CAROTID ARTERY OCCLUSION 1 0.0003
390 EXPOSURE DURING PREGNANCY 17 0.0003
391 INFLAMMATION 14 0.0003
392 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
393 MATERNAL EXPOSURE DURING PREGNANCY 24 0.0003
394 MALNUTRITION 3 0.0003
395 FISTULA 3 0.0003
396 CHRONIC SINUSITIS 1 0.0003
397 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
398 GASTRIC ULCER 5 0.0003
399 DEEP VEIN THROMBOSIS 17 0.0003
400 COMMUNICATION DISORDER 1 0.0003
401 CHOLESTASIS 5 0.0003
402 MUSCLE RUPTURE 1 0.0003
403 BRONCHITIS 19 0.0003
404 DYSPHONIA 15 0.0003
405 MENINGIOMA 4 0.0003
406 CERVIX CARCINOMA 1 0.0003
407 NAIL DISCOLOURATION 1 0.0003
408 RENAL CYST 2 0.0003
409 OBSTRUCTION 1 0.0003
410 BLOOD DISORDER 2 0.0002
411 FRUSTRATION TOLERANCE DECREASED 2 0.0002
412 GALLBLADDER OPERATION 1 0.0002
413 MUSCLE DISORDER 2 0.0002
414 CEREBRAL INFARCTION 6 0.0002
415 DECUBITUS ULCER 2 0.0002
416 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
417 PERIPHERAL VENOUS DISEASE 1 0.0002
418 GOITRE 1 0.0002
419 SINUSITIS 25 0.0002
420 LEG AMPUTATION 1 0.0002
421 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
422 INTESTINAL STENOSIS 1 0.0002
423 SWELLING 22 0.0002
424 LUNG NEOPLASM 1 0.0002
425 PRODUCT DISPENSING ISSUE 1 0.0002
426 PRODUCT CONTAINER ISSUE 2 0.0002
427 GENITAL HAEMORRHAGE 3 0.0002
428 IRRITABLE BOWEL SYNDROME 5 0.0002
429 PSYCHOLOGICAL TRAUMA 2 0.0002
430 HEPATIC LESION 1 0.0002
431 MUSCLE STRAIN 2 0.0002
432 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
433 IMMUNOSUPPRESSION 2 0.0002
434 ISCHAEMIC STROKE 4 0.0002
435 FACIAL PAIN 2 0.0002
436 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
437 LOSS OF LIBIDO 2 0.0002
438 NASAL CONGESTION 13 0.0002
439 PRODUCT QUALITY ISSUE 30 0.0002
440 MOOD ALTERED 6 0.0002
441 END STAGE RENAL DISEASE 4 0.0002
442 EYE OPERATION 1 0.0002
443 OVARIAN CANCER 2 0.0002
444 HYPOKALAEMIA 10 0.0002
445 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
446 MULTIPLE MYELOMA 1 0.0002
447 FEELING OF DESPAIR 1 0.0002
448 NEPHROPATHY 2 0.0002
449 OSTEONECROSIS 7 0.0002
450 BLOOD PROLACTIN INCREASED 1 0.0002
451 INFUSION RELATED REACTION 14 0.0002
452 PRE-ECLAMPSIA 1 0.0002
453 SKIN BURNING SENSATION 15 0.0002
454 AFFECT LABILITY 2 0.0002
455 ANOSMIA 3 0.0002
456 ATELECTASIS 2 0.0002
457 GASTROENTERITIS 3 0.0002
458 HAEMORRHOIDS 4 0.0002
459 ASCITES 6 0.0002
460 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
461 DIABETIC NEUROPATHY 1 0.0002
462 SALIVARY HYPERSECRETION 2 0.0002
463 PREGNANCY 4 0.0002
464 PREMATURE BABY 6 0.0002
465 PRODUCT ADMINISTRATION ERROR 4 0.0002
466 DRY THROAT 2 0.0002
467 DRUG DISPENSING ERROR 3 0.0002
468 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
469 BREAST CANCER 18 0.0002
470 PETECHIAE 2 0.0002
471 PARTIAL SEIZURES 1 0.0002
472 PRODUCT USE COMPLAINT 3 0.0002
473 BLOOD LACTIC ACID INCREASED 1 0.0002
474 MOOD SWINGS 6 0.0002
475 EPISTAXIS 14 0.0002
476 OVERWEIGHT 1 0.0002
477 INJECTION SITE DISCHARGE 1 0.0002
478 BRUXISM 1 0.0002
479 BEHAVIOUR DISORDER 1 0.0002
480 CHEILITIS 1 0.0002
481 FAECES DISCOLOURED 4 0.0002
482 NORMAL NEWBORN 1 0.0002
483 ASTHENOPIA 1 0.0002
484 AUTISM SPECTRUM DISORDER 1 0.0002
485 INTESTINAL ISCHAEMIA 1 0.0002
486 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
487 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
488 INTERMENSTRUAL BLEEDING 1 0.0002
489 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
490 PANCREATITIS ACUTE 4 0.0002
491 CONTUSION 17 0.0002
492 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
493 WEIGHT INCREASED 39 0.0002
494 MOUTH SWELLING 1 0.0002
495 HYPERVENTILATION 1 0.0002
496 ELECTROLYTE IMBALANCE 2 0.0002
497 CAESAREAN SECTION 2 0.0002
498 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
499 DRUG INTERACTION 27 0.0002
500 HYPERCHLORHYDRIA 1 0.0002
501 ENERGY INCREASED 1 0.0002
502 WRIST FRACTURE 2 0.0002
503 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
504 LEUKOCYTOSIS 3 0.0002
505 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
506 CRYING 6 0.0002
507 MYALGIA 28 0.0002
508 SCHIZOPHRENIA 2 0.0002
509 FIBROMYALGIA 4 0.0002
510 MENISCUS INJURY 1 0.0002
511 APPLICATION SITE IRRITATION 2 0.0002
512 HEPATIC CIRRHOSIS 3 0.0002
513 NASAL DRYNESS 1 0.0002
514 DYSPNOEA EXERTIONAL 6 0.0002
515 INFUSION SITE SWELLING 1 0.0002
516 FLATULENCE 9 0.0002
517 ABDOMINAL PAIN LOWER 4 0.0002
518 PROTEINURIA 3 0.0002
519 CARDIOVASCULAR DISORDER 4 0.0002
520 FEELING JITTERY 3 0.0002
521 PROCTALGIA 1 0.0002
522 ANOREXIA 2 0.0002
523 ERUCTATION 3 0.0002
524 EAR PAIN 3 0.0002
525 ANGINA UNSTABLE 1 0.0002
526 DYSGRAPHIA 1 0.0002
527 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
528 SINUS DISORDER 3 0.0002
529 SPINAL FRACTURE 3 0.0001
530 CHOLECYSTITIS CHRONIC 1 0.0001
531 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
532 BREAST MASS 1 0.0001
533 METASTASES TO LYMPH NODES 1 0.0001
534 PRODUCT LABEL ISSUE 1 0.0001
535 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
536 PERIPHERAL COLDNESS 2 0.0001
537 ONYCHOCLASIS 1 0.0001
538 HAIR GROWTH ABNORMAL 1 0.0001
539 BLOOD PRESSURE INCREASED 22 0.0001
540 HYPERTRANSAMINASAEMIA 1 0.0001
541 ATRIAL FIBRILLATION 14 0.0001
542 FORMICATION 1 0.0001
543 APPLICATION SITE REACTION 1 0.0001
544 LYMPHOPENIA 2 0.0001
545 HAND FRACTURE 1 0.0001
546 EATING DISORDER 3 0.0001
547 SINUS TACHYCARDIA 2 0.0001
548 DIVERTICULUM 1 0.0001
549 JOINT INJURY 3 0.0001
550 BRONCHOSPASM 2 0.0001
551 PRODUCT SUPPLY ISSUE 1 0.0001
552 PARAESTHESIA ORAL 2 0.0001
553 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
554 PRODUCT PRESCRIBING ISSUE 3 0.0001
555 PSYCHIATRIC SYMPTOM 1 0.0001
556 CHEST PAIN 25 0.0001
557 ARTHROPOD BITE 1 0.0001
558 PARAESTHESIA 21 0.0001
559 BLOOD POTASSIUM DECREASED 4 0.0001
560 BREAST TENDERNESS 1 0.0001
561 HOT FLUSH 10 0.0001
562 URTICARIA 22 0.0001
563 VISION BLURRED 18 0.0001
564 HIP ARTHROPLASTY 2 0.0001
565 DEVICE RELATED INFECTION 2 0.0001
566 CONCUSSION 1 0.0001
567 FEMUR FRACTURE 4 0.0001
568 ABDOMINAL PAIN 30 0.0001
569 HYPOALBUMINAEMIA 1 0.0001
570 PULMONARY HAEMORRHAGE 1 0.0001
571 BRAIN FOG 2 0.0001
572 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
573 NASAL DISCOMFORT 1 0.0001
574 GINGIVAL PAIN 1 0.0001
575 ABSCESS 2 0.0001
576 DIABETIC KETOACIDOSIS 3 0.0001
577 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
578 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
579 MUSCLE TIGHTNESS 2 0.0001
580 PERIPHERAL SWELLING 19 0.0001
581 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
582 PSORIASIS 16 0.0001
583 CHOLELITHIASIS 4 0.0001
584 HICCUPS 1 0.0001
585 MULTIPLE FRACTURES 2 0.0001
586 OSTEOPOROSIS 5 0.0001
587 VENTRICULAR TACHYCARDIA 2 0.0001
588 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
589 EXPIRED PRODUCT ADMINISTERED 4 0.0001
590 DRY EYE 6 0.0001
591 ROAD TRAFFIC ACCIDENT 5 0.0001
592 ATRIAL SEPTAL DEFECT 1 0.0001
593 INFUSION SITE ERYTHEMA 1 0.0001
594 CIRCULATORY COLLAPSE 2 0.0001
595 PRODUCT USE ISSUE 22 0.0001
596 SCAR 2 0.0001
597 IRRITABILITY 7 0.0001
598 DIPLOPIA 3 0.0001
599 VERTIGO 7 0.0001
600 HEADACHE 72 0.0001
601 DEVICE USE ISSUE 2 0.0001
602 DEPRESSION 26 0.0001
603 GASTRITIS 3 0.0001
604 NASOPHARYNGITIS 21 0.0001
605 GRIP STRENGTH DECREASED 1 0.0001
606 DEPRESSED MOOD 6 0.0001
607 PRODUCT COMMUNICATION ISSUE 1 0.0001
608 PURPURA 1 0.0001
609 OSTEOMYELITIS 2 0.0001
610 PANIC ATTACK 4 0.0001
611 OFF LABEL USE 96 0.0001
612 ABNORMAL DREAMS 3 0.0001
613 NERVE COMPRESSION 1 0.0001
614 IRON DEFICIENCY ANAEMIA 1 0.0001
615 MEDICATION ERROR 6 0.0001
616 BLOOD CHOLESTEROL INCREASED 5 0.0001
617 HEPATIC ENCEPHALOPATHY 1 0.0001
618 ABORTION INDUCED 1 0.0001
619 URINARY TRACT INFECTION 18 0.0001
620 ANXIETY 30 0.0001
621 ABDOMINAL DISTENSION 11 0.0001
622 PRODUCT PACKAGING ISSUE 1 0.0001
623 EYE INFLAMMATION 1 0.0001
624 LETHARGY 6 0.0001
625 PRODUCT SUBSTITUTION ISSUE 6 0.0001
626 INTERSTITIAL LUNG DISEASE 5 0.0001
627 CHOKING 2 0.0001
628 BONE PAIN 6 0.0001
629 SURGERY 6 0.0001
630 PHARYNGEAL SWELLING 1 0.0001
631 INABILITY TO AFFORD MEDICATION 1 0.0001
632 RESPIRATORY DISORDER 3 0.0001
633 CELLULITIS 5 0.0001
634 EMPHYSEMA 1 0.0001
635 EMOTIONAL DISTRESS 12 0.0001
636 HYPOTHERMIA 1 0.0001
637 PLEURAL EFFUSION 6 0.0001
638 DYSKINESIA 4 0.0001
639 MOTOR DYSFUNCTION 1 0.0001
640 INITIAL INSOMNIA 1 0.0001
641 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
642 EMOTIONAL DISORDER 3 0.0001
643 LIMB DISCOMFORT 3 0.0001
644 TOOTH LOSS 2 0.0001
645 BONE DENSITY DECREASED 3 0.0001
646 SEIZURE 11 0.0001
647 PULMONARY EMBOLISM 9 0.0001
648 INCONTINENCE 1 0.0001
649 HYPOTHYROIDISM 3 0.0001
650 RETCHING 2 0.0001
651 WEIGHT DECREASED 26 0.0001
652 NIGHT SWEATS 3 0.0001
653 PRURITUS GENERALISED 2 0.0001
654 CHRONIC KIDNEY DISEASE 7 0.0001
655 OESOPHAGITIS 1 0.0001
656 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
657 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
658 OEDEMA PERIPHERAL 11 0.0001
659 STEVENS-JOHNSON SYNDROME 2 0.0001
660 HYPERTENSIVE CRISIS 1 0.0001
661 NECK PAIN 5 0.0001
662 THERAPY NON-RESPONDER 4 0.0001
663 OXYGEN SATURATION DECREASED 5 0.0001
664 CHROMATURIA 2 0.0001
665 IMPAIRED DRIVING ABILITY 1 0.0001
666 MYOCARDIAL ISCHAEMIA 1 0.0001
667 PRODUCT AVAILABILITY ISSUE 2 0.0001
668 DERMATITIS CONTACT 1 0.0001
669 CHOLECYSTECTOMY 1 0.0001
670 PAIN 53 0.0001
671 HYPERSENSITIVITY 16 0.0001
672 COVID-19 PNEUMONIA 1 0.0001
673 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
674 DISEASE RECURRENCE 4 0.0001
675 HYPERLIPIDAEMIA 1 0.0001
676 POLYNEUROPATHY 1 0.0001
677 FATIGUE 65 0.0001
678 MENTAL IMPAIRMENT 2 0.0001
679 ADRENAL INSUFFICIENCY 1 0.0001
680 NOCTURIA 1 0.0001
681 NEURALGIA 2 0.0001
682 DYSURIA 3 0.0001
683 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
684 INJECTION SITE MASS 3 0.0001
685 OSTEONECROSIS OF JAW 2 0.0001
686 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
687 AGEUSIA 2 0.0001
688 PNEUMONIA ASPIRATION 2 0.0001
689 INJECTION SITE DISCOLOURATION 1 0.0001
690 FLUSHING 8 0.0001
691 FLUID RETENTION 4 0.0001
692 INJECTION SITE IRRITATION 1 0.0001
693 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
694 GASTROINTESTINAL DISORDER 7 0.0001
695 DRUG RESISTANCE 2 0.0001
696 INFUSION SITE PAIN 1 0.0001
697 ANAPHYLACTIC SHOCK 2 0.0001
698 BACK PAIN 18 0.0001
699 SEDATION 2 0.0001
700 BEDRIDDEN 1 0.0001
701 ORAL CANDIDIASIS 1 0.0001
702 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
703 CONDITION AGGRAVATED 23 0.0001
704 ADVERSE REACTION 1 0.0001
705 HAIR TEXTURE ABNORMAL 1 0.0001
706 PAIN IN EXTREMITY 22 0.0001
707 JOINT RANGE OF MOTION DECREASED 1 0.0001
708 NAUSEA 59 0.0001
709 DYSPNOEA 42 0.0001
710 DISTURBANCE IN ATTENTION 4 0.0001
711 THROAT TIGHTNESS 2 0.0001
712 OEDEMA 4 0.0001
713 PALLOR 2 0.0001
714 RESPIRATORY DISTRESS 2 0.0001
715 ARTHRALGIA 30 0.0001
716 MENTAL STATUS CHANGES 2 0.0001
717 ORAL DISCOMFORT 1 0.0001
718 HUNGER 1 0.0001
719 COORDINATION ABNORMAL 1 0.0001
720 APHONIA 1 0.0001
721 DEMENTIA 2 0.0001
722 BLOOD TEST ABNORMAL 1 0.0001
723 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
724 HYPONATRAEMIA 4 0.0001
725 TARDIVE DYSKINESIA 2 0.0001
726 HYPERTENSION 15 0.0001
727 PAIN IN JAW 2 0.0001
728 MUSCULAR WEAKNESS 8 0.0001
729 PARALYSIS 1 0.0001
730 HYPERSOMNIA 2 0.0001
731 IMPAIRED QUALITY OF LIFE 1 0.0001
732 ASTHENIA 26 0.0001
733 INJECTION SITE HAEMATOMA 1 0.0001
734 HYPOKINESIA 1 0.0001
735 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
736 RASH 30 0.0001
737 LIVER FUNCTION TEST ABNORMAL 2 0.0001
738 NEEDLE ISSUE 2 0.0001
739 PALPITATIONS 8 0.0001
740 COUGH 19 0.0001
741 PSYCHOTIC DISORDER 2 0.0001
742 CARDIOMYOPATHY 1 0.0001
743 RENAL INJURY 2 0.0001
744 HAEMORRHAGE INTRACRANIAL 1 0.0001
745 THROAT IRRITATION 3 0.0001
746 BONE LOSS 1 0.0001
747 APHASIA 2 0.0001
748 NEPHROLITHIASIS 3 0.0001
749 INSURANCE ISSUE 1 0.0001
750 PHARYNGEAL OEDEMA 1 0.0001
751 PRODUCT DOSE OMISSION ISSUE 19 0.0001
752 DELUSION 1 0.0001
753 SWOLLEN TONGUE 2 0.0001
754 DYSPHAGIA 6 0.0001
755 HEAD INJURY 2 0.0001
756 PRODUCTIVE COUGH 3 0.0001
757 OBESITY 1 0.0001
758 MULTIPLE SCLEROSIS 3 0.0001
759 THROMBOSIS 5 0.0001
760 VOMITING 29 0.0001
761 DYSPEPSIA 6 0.0001
762 METASTASES TO BONE 1 0.0001
763 MANIA 1 0.0001
764 DIZZINESS 30 0.0001
765 SKIN DISORDER 2 0.0001
766 MUSCLE SPASMS 11 0.0001
767 URINARY RETENTION 2 0.0001
768 TYPE 2 DIABETES MELLITUS 2 0.0001
769 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
770 HEMIPARESIS 1 0.0001
771 HEPATIC ENZYME INCREASED 4 0.0001
772 HAEMOGLOBIN DECREASED 6 0.0001
773 PARANOIA 1 0.0001
774 NIGHTMARE 2 0.0001
775 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
776 LOCAL SWELLING 1 0.0001
777 SPEECH DISORDER 3 0.0001
778 RASH MACULAR 2 0.0001
779 EOSINOPHILIA 1 0.0001
780 AMENORRHOEA 1 0.0001
781 METASTASES TO LIVER 1 0.0001
782 PANCREATITIS 3 0.0001
783 SLEEP DISORDER 4 0.0001
784 GALLBLADDER DISORDER 1 0.0001
785 PRODUCT ADHESION ISSUE 2 0.0001
786 DIARRHOEA 36 0.0001
787 DRUG EFFECT DECREASED 3 0.0001
788 PELVIC PAIN 1 0.0001
789 C-REACTIVE PROTEIN INCREASED 2 0.0001
790 LOSS OF CONSCIOUSNESS 7 0.0001
791 TREMOR 9 0.0001
792 DRUG INEFFECTIVE 71 0.0001
793 INFLUENZA 6 0.0001
794 HEPATIC STEATOSIS 1 0.0001
795 MIDDLE INSOMNIA 1 0.0001
796 UNEVALUABLE EVENT 4 0.0001
797 FOOT FRACTURE 1 0.0001
798 RENAL FAILURE 7 0.0001
799 BLOOD URINE PRESENT 1 0.0001
800 INSOMNIA 14 0.0001
801 DIABETES MELLITUS 4 0.0001
802 PULMONARY FIBROSIS 1 0.0001
803 DRUG PRESCRIBING ERROR 1 0.0001
804 GLAUCOMA 1 0.0001
805 PRESCRIBED OVERDOSE 1 0.0001
806 DYSTONIA 1 0.0001
807 ALOPECIA 10 0.0001
808 DISABILITY 1 0.0001
809 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
810 CATARACT 3 0.0001
811 INJECTION SITE BRUISING 4 0.0001
812 SOMNOLENCE 10 0.0000
813 PRODUCT PHYSICAL ISSUE 1 0.0000
814 ILL-DEFINED DISORDER 3 0.0000
815 DISCOMFORT 3 0.0000
816 BLINDNESS 2 0.0000
817 BODY TEMPERATURE INCREASED 1 0.0000
818 FEELING HOT 3 0.0000
819 VISUAL IMPAIRMENT 6 0.0000
820 FALL 16 0.0000
821 POLLAKIURIA 2 0.0000
822 CARDIO-RESPIRATORY ARREST 2 0.0000
823 WITHDRAWAL SYNDROME 2 0.0000
824 RENAL IMPAIRMENT 4 0.0000
825 HALLUCINATION, VISUAL 1 0.0000
826 CEREBROVASCULAR ACCIDENT 8 0.0000
827 IMPAIRED WORK ABILITY 1 0.0000
828 HYPOAESTHESIA 7 0.0000
829 HYPERHIDROSIS 6 0.0000
830 HYPOACUSIS 2 0.0000
831 POOR QUALITY SLEEP 1 0.0000
832 AMNESIA 3 0.0000
833 MENTAL DISORDER 2 0.0000
834 PRODUCT DISPENSING ERROR 1 0.0000
835 FEELING ABNORMAL 11 0.0000
836 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
837 COVID-19 8 0.0000
838 DEVICE DIFFICULT TO USE 3 0.0000
839 ANGIOEDEMA 2 0.0000
840 HYPOTENSION 9 0.0000
841 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
842 HEART RATE IRREGULAR 1 0.0000
843 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
844 SUICIDAL IDEATION 4 0.0000
845 MEMORY IMPAIRMENT 6 0.0000
846 SKIN IRRITATION 2 0.0000
847 SKIN DISCOLOURATION 2 0.0000
848 MALAISE 19 0.0000
849 OROPHARYNGEAL PAIN 4 0.0000
850 RENAL DISORDER 2 0.0000
851 COGNITIVE DISORDER 2 0.0000
852 ARRHYTHMIA 2 0.0000
853 PRODUCT PRESCRIBING ERROR 1 0.0000
854 THERAPY INTERRUPTED 3 0.0000
855 ABDOMINAL DISCOMFORT 7 0.0000
856 DRUG INTOLERANCE 4 0.0000
857 HYPOGLYCAEMIA 2 0.0000
858 UNDERDOSE 3 0.0000
859 LUNG DISORDER 2 0.0000
860 INJECTION SITE URTICARIA 1 0.0000
861 ABASIA 1 0.0000
862 HEART RATE INCREASED 4 0.0000
863 EXTRAPYRAMIDAL DISORDER 1 0.0000
864 AGGRESSION 2 0.0000
865 ACNE 3 0.0000
866 DECREASED APPETITE 9 0.0000
867 RASH GENERALISED 1 0.0000
868 DEAFNESS 1 0.0000
869 DERMATITIS ATOPIC 2 0.0000
870 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
871 FEAR 1 0.0000
872 CONFUSIONAL STATE 6 0.0000
873 BLOOD BILIRUBIN INCREASED 1 0.0000
874 RASH PRURITIC 2 0.0000
875 PROCEDURAL PAIN 1 0.0000
876 ARTHROPATHY 2 0.0000
877 FEELING COLD 1 0.0000
878 BLISTER 2 0.0000
879 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
880 ASTHMA 4 0.0000
881 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
882 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
883 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
884 BALANCE DISORDER 3 0.0000
885 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
886 ACUTE MYOCARDIAL INFARCTION 1 0.0000
887 ADVERSE DRUG REACTION 3 0.0000
888 CORONARY ARTERY DISEASE 1 0.0000
889 THERAPEUTIC RESPONSE DECREASED 2 0.0000
890 EPILEPSY 1 0.0000
891 DRUG ADMINISTRATION ERROR 1 0.0000
892 CONSTIPATION 7 0.0000
893 DRUG-INDUCED LIVER INJURY 1 0.0000
894 NEUROPATHY PERIPHERAL 3 0.0000
895 GAIT DISTURBANCE 6 0.0000
896 PRURITUS 12 0.0000
897 MOVEMENT DISORDER 1 0.0000
898 HIP FRACTURE 1 0.0000
899 RHINORRHOEA 2 0.0000
900 SWELLING FACE 2 0.0000
901 IMPAIRED HEALING 1 0.0000
902 EYE DISORDER 1 0.0000
903 LIP SWELLING 1 0.0000
904 DEHYDRATION 4 0.0000
905 NEOPLASM MALIGNANT 2 0.0000
906 INJECTION SITE PRURITUS 2 0.0000
907 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
908 ANGER 1 0.0000
909 INJECTION SITE PAIN 9 0.0000
910 CHEST DISCOMFORT 3 0.0000
911 HAEMORRHAGE 3 0.0000
912 HYPOXIA 1 0.0000
913 LYMPHADENOPATHY 1 0.0000
914 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
915 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
916 CEREBRAL HAEMORRHAGE 1 0.0000
917 OVERDOSE 6 0.0000
918 DRUG EFFECT INCOMPLETE 1 0.0000
919 HYPERGLYCAEMIA 1 0.0000
920 RESPIRATORY FAILURE 2 0.0000
921 SEPSIS 3 0.0000
922 EYE SWELLING 1 0.0000
923 DYSARTHRIA 1 0.0000
924 RHEUMATOID ARTHRITIS 3 0.0000
925 COLITIS 1 0.0000
926 INCORRECT DOSE ADMINISTERED 6 0.0000
927 INJECTION SITE SWELLING 2 0.0000
928 PLASMA CELL MYELOMA 1 0.0000
929 DRUG DOSE OMISSION BY DEVICE 2 0.0000
930 ABNORMAL BEHAVIOUR 1 0.0000
931 DISORIENTATION 1 0.0000
932 INJECTION SITE HAEMORRHAGE 2 0.0000
933 CARDIAC FAILURE 2 0.0000
934 EXTRA DOSE ADMINISTERED 1 0.0000
935 DRY MOUTH 2 0.0000
936 DEVICE BREAKAGE 1 0.0000
937 ERYTHEMA 5 0.0000
938 INFLUENZA LIKE ILLNESS 2 0.0000
939 ABDOMINAL PAIN UPPER 5 0.0000
940 COMPLETED SUICIDE 2 0.0000
941 SKIN EXFOLIATION 2 0.0000
942 OSTEOARTHRITIS 1 0.0000
943 PRODUCT STORAGE ERROR 2 0.0000
944 MUSCULOSKELETAL STIFFNESS 2 0.0000
945 DRUG WITHDRAWAL SYNDROME 2 0.0000
946 DRY SKIN 3 0.0000
947 COLITIS ULCERATIVE 1 0.0000
948 PULMONARY OEDEMA 1 0.0000
949 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
950 PNEUMONIA 7 0.0000
951 OCULAR HYPERAEMIA 1 0.0000
952 RASH ERYTHEMATOUS 1 0.0000
953 LEUKOPENIA 1 0.0000
954 ILLNESS 2 0.0000
955 NERVOUSNESS 1 0.0000
956 DEPENDENCE 1 0.0000
957 DRUG DOSE OMISSION 3 0.0000
958 PANCYTOPENIA 1 0.0000
959 THROMBOCYTOPENIA 2 0.0000
960 CHILLS 2 0.0000
961 JOINT SWELLING 2 0.0000
962 INJECTION SITE ERYTHEMA 2 0.0000
963 ANAEMIA 3 0.0000
964 PRODUCT DOSE OMISSION 1 0.0000
965 FEBRILE NEUTROPENIA 1 0.0000
966 BLOOD PRESSURE DECREASED 1 0.0000
967 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
968 INJECTION SITE REACTION 1 0.0000
969 PYREXIA 5 0.0000
970 DEVICE MALFUNCTION 1 0.0000
971 INJURY 1 0.0000
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
973 DYSGEUSIA 1 0.0000
974 HALLUCINATION 1 0.0000
975 ACUTE KIDNEY INJURY 2 0.0000
976 ARTHRITIS 1 0.0000
977 DRUG DEPENDENCE 2 0.0000
978 CARDIAC ARREST 1 0.0000
979 MYOCARDIAL INFARCTION 2 0.0000
980 INTENTIONAL PRODUCT MISUSE 1 0.0000
981 ADVERSE EVENT 1 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
983 DISEASE PROGRESSION 1 0.0000
984 NEUTROPENIA 1 0.0000
985 INFECTION 1 0.0000
986 HOSPITALISATION 1 0.0000
987 DEATH 5 0.0000